Actualmente, dentro de esta familia de frmacos se encuentra la sitagliptina, saxagliptina, vildagliptina y linagliptina
Clinical trials show that patients on GLP-1 agonists typically reduce calorie intake by 1520% without conscious restriction, because the medication reduces the neurological drive to overeat
When to stop treatment or seek urgent advice : Severe or persistent abdominal pain Significant increase in diarrhoea frequency or blood in stools Signs of dehydration (reduced urine output, dizziness, dry mouth) Symptoms suggesting Crohn's flare (fever, weight loss beyond expected, severe fatigue) Inability to tolerate oral intake due to nausea or vomiting Right upper quadrant pain, jaundice or fever (possible gallbladder disease) Patients should have direct access to their gastroenterology team and clear instructions on when to seek urgent medical review
The medications available now have substantial trial evidence, established safety profiles, and known cost paths
On average, clients can expect to pay between $650 and $1,349 per month for semaglutide GLP-1 treatment
GI issues, particularly vomiting and nausea, were the most frequently mentioned side effects